参考文献/References:
[1] 孙晓玲,莫秋,王冬纳,等.多囊卵巢综合征不孕症患者着床窗期子宫内膜容受性情况及促排卵治疗对其的影响[J].吉林医学,2016,37(12):2843-2844.
[2] 李友云,张丽,邢素娟,等.加味桂枝茯苓汤对多囊卵巢综合征血清抗苗勒管激素及子宫内膜容受性的影响[J].世界中医药,2018,13(12):3035-3038,3042.
[3] 管海云,张炜.多囊卵巢综合征对子宫内膜容受性的影响[J].生殖医学杂志,2016,25(12):1122-1125.
[4] TSAMPALAS M,GRIDELET V,BERNDT S,et al.Human chorionic gonadotropin:a hormonewith immunological and angiogenic properties[J].Reprod Immunol,2010,85(1):93-98.
[5] KOL S,HUMAIDAN P.LH (as HCG) and FSH surges for final oocyte maturation:sometimes it takes two to tango[J].Reprod Biomed Online,2010,21(5):590-592.
[6] ROTTERDAM ESHRE/ASRM-SPONSORED PCOS CONSENSUS WORKSHOP GROUP.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J].Hum Reprod,2004,19(1):41-47.
[7] AMJADI F,AFLATOONIAN R,JAVANMARD S H,et al.Apoli-poprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome:a case-control study[J].J Res Med Sci,2015,20(11):1039-1045.
[8] 齐家,孙赟,陈子江.多囊卵巢综合征子宫内膜胰岛素抵抗的分子机制及生物学效应[J].中华生殖与避孕杂志,2018,38(6):513-516.
[9] 于彩虹,刘梅梅,李肖肖,等.多囊卵巢综合征(PCOS)患者子宫内膜容受性的研究进展[J].中国优生与遗传杂志,2016,24(10):131-133.
[10] 王会妍,张帅,张云山.胚胎移植前宫腔内灌注hCG在IVF-ET中的应用及hCG提高种植率和妊娠率的有关机制[J].生殖与避孕,2012,32(9):593-598.
[11] LICHT P,LOSCH A,DITTRICH R,et al.Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis[J].Hum Reprod Update,1998,4(5):532-538.
[12] MANSOUR R,TAWAB N,KAMAL O,et al.Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection:a prospective randomized study[J].Fertil Steril,2011,96(6):1370-1374.
[13] 朱桂金.胞饮突与子宫内膜容受性[J].国外医学妇产科学分册,2000,27(3):131-134.
[14] 何元曼.子宫内膜容受性的评估及其改善对策[A].中国中西医结合学会妇产科专业委员会.第9届中国中西医结合学会妇产科专业委员会第二次学术会议论文集[C].北京:中国学术期刊电子出版社,2017:431-433.
[15] 黄建贞,王瑛,马建敏,等.宫内膜胞饮突及雌孕激素受体预测冻融胚胎种植窗[J].当代医学,2017,23(2):1-3.
相似文献/References:
[1]张婷婷,杨 君,王慧玲.血清维生素D和C-反应蛋白水平与多囊卵巢综合征发病的相关性分析[J].新乡医学院学报,2021,38(10):949.[doi:10.7683/xxyxyxb.2021.10.010]
ZHANG Tingting,YANG Jun,WANG Huiling.Correlation analysis of serum vitamin D and C-reactive protein levels with polycystic ovary syndrome[J].Journal of Xinxiang Medical University,2021,38(7):949.[doi:10.7683/xxyxyxb.2021.10.010]
[2]张小琼,谢 涛,汪文雁,等.肥胖型多囊卵巢综合征孕妇血清β细胞营养因子和性激素水平与不良妊娠结局的关系[J].新乡医学院学报,2021,38(9):851.[doi:10.7683/xxyxyxb.2021.09.011]
ZHANG Xiaoqiong,XIE Tao,WANG Wenyan,et al.Relationship between the serum betatrophin and sex hormones levels and adverse pregnancy outcomes in pregnant women with obese polycystic ovary syndrome[J].Journal of Xinxiang Medical University,2021,38(7):851.[doi:10.7683/xxyxyxb.2021.09.011]
[3]李晓凡,张 宁.多囊卵巢综合征与心理应激中西医研究进展[J].新乡医学院学报,2021,38(12):1185.[doi:10.7683/xxyxyxb.2021.12.016]
[4]张颖颖,王慧玲,杨 君.多囊卵巢综合征患者血清磷酸化哺乳动物雷帕霉素靶蛋白表达及临床意义[J].新乡医学院学报,2022,39(1):025.[doi:10.7683/xxyxyxb.2022.01.006]
ZHANG Yingying,WANG Huiling,YANG Jun.Expression and clinical significance of serum phosphorylated mammal target of rapamycin of patients with polycystic ovary syndrome[J].Journal of Xinxiang Medical University,2022,39(7):025.[doi:10.7683/xxyxyxb.2022.01.006]
[5]周婷婷,谈 勇.维生素D及氧化应激在多囊卵巢综合征中的作用研究进展[J].新乡医学院学报,2019,36(2):198.[doi:10.7683/xxyxyxb.2019.02.025]
[6]冯塬媛,刘 煜,李 沫,等.多囊卵巢综合征患者发病机制及其治疗研究进展[J].新乡医学院学报,2017,34(6):548.[doi:10.7683/xxyxyxb.2017.06.027]
[7]孙畅,潘紫萌,韩鹏光,等.多囊卵巢综合征患者肠道微生物群结构变化及其在代际效应中的作用机制研究进展[J].新乡医学院学报,2023,40(1):084.[doi:10.7683/xxyxyxb.2023.01.015]
SUN Chang,PAN Zimeng,HAN Pengguang,et al.Research progress on structural changes of intestinal microbiota in patients with polycystic ovary syndrome and its mechanism in intergenerational effect[J].Journal of Xinxiang Medical University,2023,40(7):084.[doi:10.7683/xxyxyxb.2023.01.015]
[8]许鑫,杨君,赵金金,等.雷帕霉素对多囊卵巢综合征大鼠子宫内膜的作用及机制[J].新乡医学院学报,2023,40(9):818.[doi:10.7683/xxyxyxb.2023.09.003]
XU Xin,YANG Jun,ZHAO Jinjin,et al.Effect and mechanism of rapamycin on endometrium of rats with polycystic ovary syndrome[J].Journal of Xinxiang Medical University,2023,40(7):818.[doi:10.7683/xxyxyxb.2023.09.003]